This pilot clinical trial evaluates whether non-invasive brain stimulation improves the orientation and mobility (O\&M) skills of individuals with constricted visual fields in both eyes. The study is composed of three visits. The first visit is meant to confirm eligibility by performing a few clinical tests. Eligible participants will then complete two additional visits, one in which the participants receive active stimulation, and one in which the participants receive placebo (sham) stimulation. Stimulation will be administered in a randomized, double-blind order. To evaluate improvement, various measures of O\&M performance will be assessed on a standardized obstacle course featuring static natural and artificial obstacles at defined intervals after the intervention. The investigators hypothesize that the application of brain stimulation to region of the brain responsible for visual processing will improve the orientation and mobility skills of individuals with binocular constricted visual fields immediately following stimulation, and the results will inform the design of a future, larger-scale study.
This within-subject crossover pilot study involves applying a weak focused electrical current to the head, to target areas of visual processing, more specifically the primary visual cortex (V1) within the occipital pole. The purpose of this study is to investigate the efficacy of high-frequency transcranial random noise stimulation (hf-tRNS), a safe and well-established form of brain stimulation on O\&M performance of individuals with constricted visual fields in both eyes due to either retinitis pigmentosa (RP), rod-cone dystrophy, or advanced glaucoma. Participants will be recruited from university-affiliated clinics as well as local clinical practices. After obtaining full informed consent at the first visit, participants will complete clinical tests to confirm that the eligibility criteria of the study are met. These tests include measuring the participant's corrected binocular distance and near visual acuities, binocular contrast sensitivity, binocularity, as well as peripheral visual fields. Researchers will also ensure that it safe for the participant to undergo brain stimulation using a list of contraindicators for brain stimulation interventions and verify that participants are free from physical or motor impairments as well as vestibular disorders or dysfunctions that can impact the participant's walking and balancing abilities. During the two subsequent visits, the effects of stimulation (which lasts 20 minutes) will be studied 2 and 30 minutes after stimulation. To evaluate improvement, various measures of O\&M performance will be targeted as participants complete an O\&M course divided into 4 sections and composed of an array of static natural and artificial (man-made) obstacles. Participants will be instructed to walk along the various sections at a comfortable pace, safely negotiating the obstacles without touching any of the obstacles. Participants will also be told in which sections obstacles will be encounter. Static natural obstacles refer to fixed/steady/stable obstacles that are either readily found in the environment (e.g., potted plants) or form part of the architecture of the building (e.g., a pole or a sealed doorway). Artificial obstacles are made of light materials such as polystyrene, rubber foam, soft cardboard, or paper. Static natural/real obstacles will be at foot level, foot to knee height, as well as shoulder and head heights, whereas artificial obstacles will be placed either above the knee, waist, at the shoulder or head height. Individuals with constricted field loss in both eyes who use a long white cane for travelling and have received O\&M training (including caning skills) from an orientation and mobility professional will be asked to complete the course with their cane. However, individuals with constricted visual field in both eyes who do not use a cane can also complete the same course. Measures of performance include the primary outcome measure percentage preferred walking speed (PPWS), that is the walking speed of the individual who is visually impaired in an environment with obstacles expressed as a percentage of their preferred walking speed in an unobstructed path. Secondary outcome measures include: the time taken to complete each of the 4 sections of the course, the number of O\&M errors, visual detection distance (VDD) (the distance at which an individual detects an obstacle in the travel path, even if it cannot be identified), and visual identification distance (VID) (the distance at which an individual can correctly identify an obstacle in the travel path). Course section #1 will not consist of obstacles. The time taken to complete the course section, number of O\&M errors, and preferred walking speed in an unobstructed path (obtained from the completion time and length of the straight, flat path) will be measured. Course section #2 will consist of obstacles and will be an indoor space leading to a more opened space within the building. The time taken to complete the course section, number of O\&M errors, and preferred walking speed in an obstructed path (obtained from the completion time and length of the path) will be measured. The percentage preferred walking speed (PPWS) will be calculated. PPWS is the preferred walking speed of the individual in course section #2 expressed as a percentage of the participant's preferred walking speed in course section #1. Course sections #3 and #4 will be used for measuring VDD and VID. Each course will be a straight indoor corridor consisting of only one obstacle, and the obstacle will be different for each of the two sections. Moreover, course section #3 will be used as a training course for measuring VDD and VID. The time taken to complete the course section, number of O\&M errors, visual detection distance (VDD), and visual identification distance (VID) will be measured in course sections #3 and #4. It is important to note that for course sections with obstacles (course sections # 2 to 4), the location of the obstacles in each trial (pre, post 1, and post 2) will not be varied, but rather the location of the obstacles on each treatment day will be randomized. In addition, two researchers will always be with the participant at all times. One will be with the participant to provide instructions and record data; whilst the other will be ahead of the participant to make sure the path is clear, record the times, and confirm that the obstacles are still in place (when applicable), as well as videorecord the session once consent was obtained from the participant at the first visit. By videorecording the participant as the course task is completed, the researchers will be able to obtain more accurate measures of time, and the number of O\&M errors. There will be two stimulation sessions (one with active stimulation and one with placebo (the order will be randomized so that neither the participant nor the researcher will know what the subject will receive)). At the two stimulation sessions the primary and secondary outcome measures will be evaluated as the participant completes the O\&M course before stimulation (O\&M pretest), as well as 2 mins after stimulation (O\&M post-test 1/immediately after stimulation), and 30 mins after stimulation (O\&M post-test 2/30 minutes after stimulation). The investigators hypothesize that the application of hf-tRNS to V1 will improve the orientation and mobility skills of individuals with constricted visual fields immediately following stimulation as a result of an increase in the cortical excitability of the stimulated brain cells, which consequently leads to peripheral vision and contrast sensitivity enhancements, thereby allowing the participants to safely detect objects and obstacles in the travel path. The objective of this study is to improve the fundamental visual processes of individuals with constricted visual fields using hf-tRNS. From a scientific perspective, the investigators hope to discover whether brain stimulation can serve as an additional rehabilitation tool for improving the O\&M skills of individuals with constricted visual fields. Investigators expect that participants will experience temporary O\&M improvements, however, there will not be any lasting improvements in O\&M skills from such a single session within subject study design. If the results of this study show a positive effect, the data will be used to power a larger study. All procedures will occur at the Human Visual Neuroscience Laboratory, University of Waterloo, Ontario, Canada.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
20
Active hf-tRNS: A weak alternating electric current is applied to the head through two electrodes to affect the cortical excitability of the targeted cells in the brain. Stimulation instrument: neuroConn DC Stimulator Plus 2019 (Direct current stimulator Model number 0021, power: 1.2 W, charger: 2.9 V (maximum 160 mA)) (neurocaregroup.com), or neuroConn DC Stimulator MC 2016 (Multi-channel stimulator Model number 0028, power: 24 W, rating: 12 V (maximum 2 A)) (neurocaregroup.com).
Placebo/sham hf-tRNS: The tRNS machine will be used as in active stimulation, except the electrical current will not be applied. Stimulation instrument: neuroConn DC Stimulator Plus 2019 (Direct current stimulator Model number 0021, power: 1.2 W, charger: 2.9 V (maximum 160 mA)) (neurocaregroup.com), or neuroConn DC Stimulator MC 2016 (Multi-channel stimulator Model number 0028, power: 24 W, rating: 12 V (maximum 2 A)) (neurocaregroup.com).
University of Waterloo, School of Optometry and Vision Science
Waterloo, Ontario, Canada
Percentage preferred walking speed (PPWS)
* Change in Percentage preferred walking speed (PPWS (%)) before and right after (2 mins) active stimulation. * Change in Percentage preferred walking speed (PPWS (%)) before and 30-minutes after active stimulation. * Change in Percentage preferred walking speed (PPWS (%)) before and right after (2 mins) placebo/sham stimulation. * Change in Percentage preferred walking speed (PPWS (%)) before and 30-minutes after placebo/sham stimulation. * Behavioural Measure: The participant will first complete section #1, which is obstacle free. The time taken to complete the section and preferred walking speed in an unobstructed path (obtained from the completion time and length of the straight, flat path) will be measured. They will then proceed to complete section #2, which has obstacles. The time taken to complete the section, and preferred walking speed in an obstructed path will be measured. PPWS= (preferred walking speed course 1/ preferred walking speed course 2)\*100.
Time frame: The pre-test and post-tests will take roughly 2 hours to complete.
Visual detection distance (VDD)
* Change in Visual detection distance (VDD (m)) before and right after (2 mins) active stimulation. * Change in Visual detection distance (VDD (m)) before and 30-minutes after active stimulation. * Change in Visual detection distance (VDD (m)) before and right after (2 mins) placebo/sham stimulation. * Change in Visual detection distance (VDD (m)) before and 30-minutes after placebo/sham stimulation. * Behavioural Measure: Participants will be instructed to walk along the various sections at a comfortable pace, safely negotiating the obstacle without touching any of them. The participant will complete sections #3 and #4. Each section will be a straight indoor corridor consisting of only one obstacle. Moreover, section #3 will be used as a training course, whereas section #4 is meant to collect data. The time it takes to first detect the obstacle and the distance from the participant to the obstacle, the moment it is first detected will be measured. This distance is VDD.
Time frame: The pre-test and post-tests will take roughly 2 hours to complete.
Visual identification distance (VID)
* Change in Visual identification distance (VID (m)) before and right after (2 mins) active stimulation. * Change in Visual identification distance (VID (m)) before and 30-minutes after active stimulation. * Change in Visual identification distance (VID (m)) before and right after (2 mins) placebo/sham stimulation. * Change in Visual identification distance (VID (m)) before and 30-minutes after placebo/sham stimulation. * Behavioural Measure: Participants will be instructed to walk along the various sections at a comfortable pace, safely negotiating the obstacle without touching any of them. The participant will complete sections #3 and #4. Each section will be a straight indoor corridor consisting of one obstacle. Section #3 will be used for training, whereas section #4 is meant to collect data. The time it takes to correctly identify the obstacle just detected, and the distance from the participant to the obstacle, the moment they first identify it will be measured (VID).
Time frame: The pre-test and post-tests will take roughly 2 hours to complete.
Number of orientation and mobility errors.
* Change in number of errors (count) before and right after (2 mins) active stimulation for course section (done for each section 1, 2, 4). * Change in number of errors (count) before and right after 30-minutes after active stimulation for course section (done for each section 1, 2, 4). * Change in number of errors (count) before and right after (2 mins) placebo/sham stimulation for course section (done for each section 1, 2, 4). * Change in number of errors (count) before and right after 30-minutes after placebo/sham stimulation for course section (done for each section 1, 2, 4). Participants will be instructed to walk along the various sections at a comfortable pace, safely negotiating any obstacles which may be present without touching any of them. The researcher will carefully observe them and note the number of errors (e.g. mobility errors- bumping into objects, orientation errors-deviations to name a few). See protocol outline document for exact error definitions.
Time frame: The pre-test and post-tests will take roughly 2 hours to complete.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.